Nanobiotix S.A. (NBTX) Form 6-K — May 22, 2026
Nanobiotix announced the full exercise of the underwriters' over-allotment option in its global offering, bringing total gross proceeds to approximately $100 million. The offering includes 2,218,467 ordinary shares and pre-funded warrants, priced at $38.98 per ADS, which represents a 14.92% discount to the recent volume-weighted average price. The company intends to allocate less than 10% of the net proceeds to the development of JNJ-1900 (NBTXR3), while 50-60% will support the advancement of its Nanoprimer and other platforms. The remaining 30-40% will be used for general corporate purposes, with management retaining broad discretion over allocation.
Key figures
- Gross Proceeds
- 100000000
- Offering Price
- 38.98
- Shares Offered
- 2218467
- Ads Issued
- 259178
- Discount To Vwap
- 14.92%
- Cash Runway Extension
- into 2029
- Pre Funded Warrants Issued
- 345099
- Additional Shares From Over Allotment
- 33805
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.